Skip to main content

Is Xalkori the same as Opdivo or Keytruda?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on Jan 20, 2024.

Official Answer by Drugs.com

Xalkori is not the same as Opdivo or Keytruda, but all three are prescription drugs used to treat serious cancers, such as non-small cell lung cancer (NSCLC) or lymphoma (a type of blood cancer). Xalkori is an oral medicine, but Opdivo and Keytruda are given as intravenous (IV) infusions.

Xalkori (generic name: crizotinib) is considered a targeted drug therapy known as a tyrosine kinase inhibitor. It kills cancer cells by targeting a specific area in the cell that leads to the cancer.

Opdivo (nivolumab) and Keytruda (pembrolizumab) are biologic medicines called immune checkpoint inhibitors. They work in cancer by helping your own immune system to fight the cancer.

References

Read next

What is the success rate of Keytruda?

In general, PD-1 immune checkpoint inhibitors like Keytruda have been shown to significantly prolong overall survival (OS) in some patients with various cancer types, but Keytruda does not always work for everyone. Continue reading

How long does it take for Keytruda to work?

The time it takes for Keytruda to work can vary based on the type and stage of cancer. Typically, a response to treatment becomes apparent within 2-4 months of starting Keytruda. This timeframe is referred to as "time to response," which measures when a patient's cancer begins to show signs of responding to the treatment. You can find the specific "time to response" data from clinical trials in the table below. Continue reading

What are monoclonal antibodies?

Monoclonal antibodies (mAbs) are man-made proteins that mimic the natural antibodies produced by our immune systems. Monoclonal antibodies can be formulated into medicines to treat various types of illnesses, such as cancer, rheumatoid arthritis or psoriasis. Continue reading

See also:

Related medical questions

Drug information

Related support groups